Search

Search Constraints

You searched for: Author/Creator Begini, P.

Search Results

1. AF.90 RISK FACTORS FOR LIVER DECOMPENSATION AND HCC IN HCV-CIRRHOTIC PATIENTS AFTER DAAS: A MULTICENTER PROSPECTIVE STUDY. (September 2021)

2. Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group. (10th February 2016)

3. SARCOPENIA IS ASSOCIATED WITH A REDUCED SURVIVAL IN PATIENTS WITH HEPATOCARCINOMA UNDERGOING SORAFENIB TREATMENT. (15th February 2015)

5. Overall survival and incidence of liver-related events in a cohort of cirrhotic patients treated with direct antiviral agents: results from a multicenter study. (February 2019)

6. Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Issue 1 (February 2018)